Abstract

Being overweight or obese is a significant public health problem in the 21st century due to its scale, common existence and its cause-effect association with multiple diseases. Excessive accumulation of adipose tissue in humans is regarded as a major risk factor for development of cardiovascular and skeletal diseases. However, data from recent years have revealed that obesity is also strongly associated with increased risk of the majority of cancers in humans, including those originating from the gastrointestinal tract. During the last few year this association has been thoroughly proven and supported by several epidemiological analyses. The authors present i) the current state of knowledge regarding key (patho)mechanisms that link metabolism of human adipose tissue to development/progression of neoplasms (especially in the gastrointestinal tract), as well as ii) the results of selected clinical studies in which the influence of obesity on risk of gastrointestinal cancer development has been addressed.

References

• 1. Alemán J.O., Eusebi L.H., Ricciardiello L., Patidar K., Sanyal A.J.,Holt P.R.: Mechanisms of obesity-induced gastrointestinal neoplasia.Gastroenterology, 2014; 146: 357-373
  Google Scholar
• 2. Bardou M., Barkun A.N., Martel M.: Obesity and colorectal cancer.Gut, 2013; 62: 933-947
  Google Scholar
• 3. Berrington de Gonzalez A., Sweetland S., Spencer E.: A metaanalysisof obesity and the risk of pancreatic cancer. Br. J. Cancer,2003; 89: 519-523
  Google Scholar
• 4. Błogowski W., Budkowska M., Sałata D., Serwin K., DołęgowskaB., Łokaj M., Prowans P., Starzyńska T.: Clinical analysis of selectedcomplement-derived molecules in human adipose tissue. J. Transl.Med., 2013; 11: 11
  Google Scholar
• 5. Błogowski W., Ratajczak M.Z., Żyżniewska-Banaszak E.,Dołęgowska B., Starzyńska T.: Adipose tissue as a potential sourceof hematopoietic stem/progenitor cells. Obesity, 2012; 20: 923-931
  Google Scholar
• 6. Błogowski W., Serwin K., Sałata D., Budkowska M., Dołęgowska B.,Łokaj M.., Prowans P., Starzyńska T.: Plasma and adipose tissue levelsof selected growth/inhibitory factors, proteolytic enzymes and sphingosine-1-phosphatein humans. Eur. J. Inflamm., 2012; 10: 279-288
  Google Scholar
• 7. Calle E.E., Kaaks R.: Overweight, obesity and cancer: epidemiologicalevidence and proposed mechanisms. Nat. Rev. Cancer, 2004;4: 579-591
  Google Scholar
• 8. Dalamaga M., Diakopoulos K.N., Mantzoros C.S.: The role of adiponectinin cancer: a review of current evidence. Endocr. Rev., 2012;33: 547-594
  Google Scholar
• 9. Dowling R.J., Niraula S., Stambolic V., Goodwin P.J.: Metforminin cancer: translational challenges. J. Mol. Endocrinol., 2012; 48:R31-R43
  Google Scholar
• 10. Frezza E.E., Wachtel M.S., Chiriva-Internati M.: Influence of obesityon the risk of developing colon cancer. Gut, 2006; 55: 285-291
  Google Scholar
• 11. Gallagher E.J., LeRoith D.: Minireview: IGF, insulin, and cancer.Endocrinology, 2011; 152: 2546-2551
  Google Scholar
• 12. Gao J., Tian J., Lv Y., Shi F., Kong F., Shi H., Zhao L.: Leptin inducesfunctional activation of cyclooxygenase-2 through JAK2/STAT3,MAPK/ERK, and PI3K/AKT pathways in human endometrial cancercells. Cancer Sci., 2009; 100: 389-395
  Google Scholar
• 13. Genkinger J.M., Spiegelman D., Anderson K.E., Bernstein L., vanden Brandt P.A., Calle E.E., English D.R., Folsom A.R., FreudenheimJ.L., Fuchs C.S., Giles G.G., Giovannucci E., Horn-Ross P.L., LarssonS.C., Leitzmann M. i wsp.: A pooled analysis of 14 cohort studies ofanthropometric factors and pancreatic cancer risk. Int. J. Cancer,2011; 129: 1708-1717
  Google Scholar
• 14. Giovannucci E., Michaud D.: The role of obesity and related metabolicdisturbances in cancers of the colon, prostate, and pancreas;Gastroenterology, 2007; 132: 2208-2225
  Google Scholar
• 15. Harvey A.E., Lashinger L.M., Hursting S.D.: The growing challengeof obesity and cancer: an inflammatory issue. Ann. N.Y. Acad.Sci., 2011; 1229: 45-52
  Google Scholar
• 16. Hegde S.R., Sun W., Lynch J.P.: Systemic and targeted therapyfor advanced colon cancer. Expert. Rev. Gastroenterol. Hepatol.,2008; 2: 135-149
  Google Scholar
• 17. Hoyo C., Cook M.B., Kamangar F., Freedman N.D., WhitemanD.C., Bernstein L., Brown L.M., Risch H.A., Ye W., Sharp L., Wu A.H.,Ward M.H., Casson A.G., Murray L.J., Corley D.A., Nyren O., PandeyaN., Vaughan T.L., Chow W.H., Gammon M.D.: Body mass index in relationto oesophageal and oesophagogastric junction adenocarcinomas:a pooled analysis from the International BEACON Consortium.Int. J. Epidemiol., 2012; 41: 1706-1718
  Google Scholar
• 18. Hursting S.D., Smith S.M., Lashinger L.M., Harvey A.E., PerkinsS.N.: Calories and carcinogenesis: lessons learned from 30 years ofcalorie restriction research. Carcinogenesis, 2010; 31: 83-89
  Google Scholar
• 19. Huxley R., Ansary-Moghaddam A., Barzi F., Woodward M.: TypeIIdiabetes and pancreatic cancer: a meta-analysis of 36 studies. Br.J. Cancer, 2005; 92: 2076-2083
  Google Scholar
• 20. Jaffe T., Schwartz B.: Leptin promotes motility and invasivenessin human colon cancer cells by activating multiple signal-transductionpathways. Int. J. Cancer, 2008; 123: 2543-2556
  Google Scholar
• 21. John B.J., Irukulla S., Abulafi A.M., Kumar D, Mendall M.A.: Systematicreview: adipose tissue, obesity and gastrointestinal disease.Aliment. Pharmacol. Therapeut., 2006; 23: 1511-1523
  Google Scholar
• 22. Kaminski M.F., Polkowski M., Kraszewska E., Rupinski M., ButrukE., Regula J.: A score to estimate the likelihood of detecting advancedcolorectal neoplasia at colonoscopy. Gut, 2014; 63: 1112-1119
  Google Scholar
• 23. Kłosiewicz-Latoszek L.: Otyłość jako problem społeczny, zdrowotnyi leczniczy. Probl. Hig. Epidemiol., 2010; 91: 339-343
  Google Scholar
• 24. Larsson S.C., Wolk A.: Obesity and the risk of gallbladder cancer:a meta-analysis. Br. J. Cancer, 2007; 96: 1457-1461
  Google Scholar
• 25. Luo J., Margolis K.L., Adami H.O., LaCroix A., Ye W.: Obesityand risk of pancreatic cancer among postmenopausal women:the Women’s Health Initiative (United States). Br. J. Cancer, 2008;99: 527-531
  Google Scholar
• 26. O’Doherty M.G., Freedman N.D., Hollenbeck A.R., Schatzkin A.,Abnet C.C.: A prospective cohort study of obesity and risk of oesophagealand gastric adenocarcinoma in the NIH-AARP Diet andHealth Study. Gut, 2012; 61: 1261-1268
  Google Scholar
• 27. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J.,Flegal K.M.: Prevalence of overweight and obesity in the UnitedStates 1996-2004. JAMA, 2006; 295: 1549-1555
  Google Scholar
• 28. Ouchi N., Parker J.L., Lugus J.J., Walsh K.: Adipokines in inflammationand metabolic disease. Nat. Rev. Immunol., 2011; 11: 85-97
  Google Scholar
• 29. Perry J.K., Liu D.X., Wu Z.S., Zhu T., Lobie P.E.: Growth hormoneand cancer: an update on progress. Curr. Opin. Endocrinol. DiabetesObes., 201; 20: 307-313
  Google Scholar
• 30. Pischon T., Lahmann P.H., Boeing H., Friedenreich C., Norat T.,Tjonneland A., Halkjaer J., Overvad K., Clavel-Chapelon F., BoutronRuaultM.C., Guernec G., Bergmann M.M., Linseisen J., Becker N.,Trichopoulou A. i wsp.: Body size and risk of colon cancer in the EuropeanProspective Investigation Into Cancer and Nutrition (EPIC).J. Natl. Cancer Inst., 2006; 98: 920-931
  Google Scholar
• 31. Polesel J., Zucchetto A., Montella M., Dal Maso L., Crispo A., LaVecchia C., Serraino D., Franceschi S., Talamini R.: The impact of obesityand diabetes mellitus on the risk of hepatocellular carcinoma.Ann. Oncol., 2009; 20: 353-357
  Google Scholar
• 32. Raimondi S., Maisonneuve P., Lowenfels A.B.: Epidemiology ofpancreatic cancer: an overwier. Nat. Rev. Gastroenterol. Hepatol.,2009; 6: 699-708
  Google Scholar
• 33. Schlesinger S., Aleksandrova K., Pischon T., Fedirko V., Jenab M.,Trepo E., Boffetta P., Dahm C.C., Overvad K., Tjønneland A., HalkjærJ., Fagherazzi G., Boutron-Ruault M.C., Carbonnel F., Kaaks R. i wsp.:Abdominal obesity, weight gain during adulthood and risk of liverand biliary tract cancer in a European cohort. Int. J. Cancer., 2013;132: 645-657
  Google Scholar
• 34. Vucenik I., Stains J.P.: Obesity and cancer risk: evidence, mechanisms,and recommendations. Ann. N Y Acad. Sci., 2012; 1271: 37-43
  Google Scholar
• 35. Whiteman D.C., Sadeghi S., Pandeya N., Smithers B.M., GotleyD.C., Bain C.J., Webb P.M., Green A.C.: Combined effects of obesity,acid reflux and smoking on the risk of adenocarcinomas of the oesophagus.Gut, 2008; 57: 173-180
  Google Scholar
• 36. Wörmann S.M., Algül H.: Risk factors and therapeutic targetsin pancreatic cancer. Front. Oncol., 2013; 3: 282
  Google Scholar
• 37. Ydav D., Lowenfels A.B.: The epidemiology of pancreatitis andpancreatic cancer. Gastroenterology, 2013; 144: 1252-1261
  Google Scholar

Full text